Clinical Trial Update: Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant immunotherapy plus chemotherapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: IIIA Stage Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING